Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Amneal Pharmaceuticals Inc (AMRX)
Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Amneal Pharmaceuticals Inc 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 USA

www.amneal.com P: 908-947-3120 F: 908-947-3146

Description:

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,416,233
Enterprise Value, $K 4,127,603
Shares Outstanding, K 306,544
Annual Sales, $ 2,212 M
Annual Net Income, $ -129,990 K
Last Quarter Sales, $ 620,040 K
Last Quarter Net Income, $ 25,030 K
EBIT, $ 226,210 K
EBITDA, $ 474,980 K
60-Month Beta 1.26
% of Insider Shareholders 26.56%
% of Institutional Shareholders 31.82%
Float, K 225,126
% Float 73.44%
Short Volume Ratio 0.34

Growth:

1-Year Return 93.98%
3-Year Return 13.24%
5-Year Return -71.32%
5-Year Revenue Growth 185.17%
5-Year Earnings Growth -4.76%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.19 on 11/07/23
Next Earnings Date N/A
Earnings Per Share ttm 0.64
EPS Growth vs. Prev Qtr 6.25%
EPS Growth vs. Prev Year 41.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AMRX Ratios

Ratio
Price/Earnings ttm 7.36
Price/Earnings forward 9.45
Price/Earnings to Growth N/A
Return-on-Equity % 109.82%
Return-on-Assets % 4.62%
Profit Margin % -5.88%
Net Margin % N/A
Debt/Equity 17.18
Price/Sales 0.65
Price/Cash Flow 3.28
Price/Book 9.26
Book Value/Share 0.50
Interest Coverage -0.57
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar